| 摘要 |
The present invention provides a HDL comprising an agent selected from the group consisting of antiproteases, antixoxidants, antimitotics, anti-apoptotic agents and agents involved in the iron metabolism for use as a medicament, in particular for the treatment of atherothrombosis, ischemic diseases, COPD and neurodegenerative diseases. |
